CytoDyn (CYDY) Net Equity Issued and Repurchased (2010 - 2026)
CytoDyn's Net Equity Issued and Repurchased came in at $900,000 for FY2026 (year ended May 31, 2026), down 16.7% from $1.08 million in FY2025.
Powered by 
Analysis
CytoDyn (CYDY) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
Going back to FY2011, CytoDyn's Net Equity Issued and Repurchased data covers 14 fiscal years.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -45.9% (FY2021 to FY2026).
- The five-year range for annual Net Equity Issued and Repurchased is $300,000 (FY2024) to $1.08 million (FY2025).
- Per Business Quant, earlier fiscal years put Net Equity Issued and Repurchased at $1.08 million in FY2025 (+260.3%), $300,000 in FY2024 (-31.7%), $439,000 in FY2023 (-57.6%) and $1.04 million in FY2022 (-94.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | CytoDyn | 274.70 Mn | 274.70 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Feb 28, 2026 | 879,000.00 |
| Aug 31, 2025 | 21,000.00 |
| May 31, 2025 | 1.06 Mn |
| Aug 31, 2023 | 300,000.00 |
| May 31, 2023 | 175,000.00 |
| Aug 31, 2022 | 264,000.00 |
| Nov 30, 2021 | 533,000.00 |
| Aug 31, 2021 | 503,000.00 |
| May 31, 2021 | 781,000.00 |
| Feb 28, 2021 | 3.44 Mn |
| Nov 30, 2020 | 1.75 Mn |
| Aug 31, 2020 | 13.46 Mn |
| May 31, 2020 | 15.11 Mn |
| Feb 29, 2020 | 12.81 Mn |
| Nov 30, 2019 | 8.25 Mn |
| Aug 31, 2019 | 2.26 Mn |
| May 31, 2018 | 1.51 Mn |
| Aug 31, 2017 | 1.65 Mn |
| May 31, 2017 | 3.00 |
| Aug 31, 2016 | 397,880.00 |
API Access
CytoDyn Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CYDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "CYDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CYDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();